APA (7th ed.) Citation

LT, G., Z, S., A, P., EA, C., JA, Z., RJ, G., . . . KT, F. (2024). Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V. JCO precision oncology, 8, e2400514. https://doi.org/10.1200/PO-24-00514

Chicago Style (17th ed.) Citation

LT, Gien, et al. "Phase II Study of Sunitinib in Tumors With C-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V." JCO Precision Oncology 8 (2024): e2400514. https://doi.org/10.1200/PO-24-00514.

MLA (9th ed.) Citation

LT, Gien, et al. "Phase II Study of Sunitinib in Tumors With C-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V." JCO Precision Oncology, vol. 8, 2024, p. e2400514, https://doi.org/10.1200/PO-24-00514.